Principal Financial Group Inc. Increases Stock Position in Semler Scientific, Inc. (NASDAQ:SMLR)

Principal Financial Group Inc. boosted its position in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) by 633.1% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 112,487 shares of the company's stock after purchasing an additional 97,144 shares during the period. Principal Financial Group Inc. owned about 1.21% of Semler Scientific worth $6,074,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Quest Partners LLC boosted its stake in shares of Semler Scientific by 48.0% in the 3rd quarter. Quest Partners LLC now owns 2,520 shares of the company's stock worth $59,000 after buying an additional 817 shares during the last quarter. US Bancorp DE lifted its holdings in Semler Scientific by 60.8% during the third quarter. US Bancorp DE now owns 3,064 shares of the company's stock worth $72,000 after acquiring an additional 1,158 shares during the period. Sanctuary Advisors LLC purchased a new position in Semler Scientific in the third quarter worth $104,000. Veery Capital LLC bought a new position in Semler Scientific in the 4th quarter valued at $324,000. Finally, GSA Capital Partners LLP increased its position in shares of Semler Scientific by 73.9% during the 3rd quarter. GSA Capital Partners LLP now owns 10,336 shares of the company's stock valued at $243,000 after purchasing an additional 4,393 shares during the last quarter. Hedge funds and other institutional investors own 49.37% of the company's stock.

Semler Scientific Stock Performance

SMLR traded down $4.03 during midday trading on Monday, reaching $38.89. The company had a trading volume of 957,668 shares, compared to its average volume of 361,868. Semler Scientific, Inc. has a 12-month low of $20.88 and a 12-month high of $81.56. The business has a 50-day moving average price of $53.96 and a two-hundred day moving average price of $43.46. The stock has a market cap of $360.39 million, a PE ratio of 7.92 and a beta of 1.17.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its quarterly earnings data on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, beating the consensus estimate of $0.20 by $3.21. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%. The business had revenue of $12.41 million for the quarter.

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital boosted their price target on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a "buy" rating in a report on Friday, January 24th.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.